Related Experiment Video
Updated: Jul 20, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART
Jerzy Jaroszewicz1, Alicja Wiercinska-Drapalo, Tadeusz W Lapinski
1Department of Infectious Diseases, Medical University of Bialystok, Bialystok, Poland.
Insights
Serum cystatin C is elevated in HIV infection, indicating potential kidney dysfunction. Long-term antiretroviral therapy (ART) may reduce cystatin C levels, suggesting improved kidney function in HIV patients.
Area of Science:
- Nephrology
- Infectious Diseases
- HIV Medicine
Background:
- Renal disease affects 2-10% of HIV-infected individuals.
- Antiretroviral (ARV) therapy can slow the progression of HIV-related kidney disease.
Purpose of the Study:
- To determine serum cystatin C levels in different stages of HIV infection.
- To investigate the relationship between cystatin C and ARV treatment.
Main Methods:
- Serum cystatin C measured in 77 HIV-1 infected and 18 HIV-seronegative individuals.
- Glomerular filtration rate (GFR) estimated using the Modification of Diet in Renal Disease Study formula.
Main Results:
- HIV infection significantly increased serum cystatin C (933.4 vs 621.1 ng/ml, P < 0.001).
- Serum cystatin C correlated with highly active antiretroviral therapy (HAART) duration (P=0.04) and HIV viral load (P=0.04).
- No significant differences in urea, creatinine, or GFR were observed between groups.
Conclusions:
- Elevated serum cystatin C in HIV may indicate mild renal dysfunction.
- Serum cystatin C is associated with HIV viral load.
- Long-term HAART may decrease cystatin C, potentially improving renal function.
Aim:
The prevalence of renal disease in human HIV-infected individuals varies between 2% and 10%. Many reports have demonstrated the beneficial effect of antiretroviral (ARV) therapy on slowing the progression of renal diseases. The aim of our cross-sectional study was to determine serum cystatin C concentration in different stages of HIV infection and the relationship between cystatin C concentration and ARV treatment.
Methods:
Cystatin C concentration was measured in the sera of 77 HIV-1-infected individuals and 18 HIV-seronegative volunteers. The glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease Study formula.
Results:
HIV infection resulted in a significant increase in serum cystatin C concentration compared with healthy individuals (933.4 +/- 32.1 vs 621.1 +/- 56.8 ng/ml, P < 0.001). There were no significant differences in urea, creatinine and GFR between those groups. On multivariate analyses serum cystatin C was independently associated with highly active antiretroviral therapy (HAART) duration (beta = -0.34, P = 0.04) and HIV viral load (beta = 0.33, P = 0.04), whereas there were no significant relationships with age, body mass index, HIV duration, CD4+ and CD8+ T-cell counts and serum high sensitivity C-reactive protein concentration.
Conclusions:
Our initial observations indicate that serum cystatin C, which may reflect mild renal dysfunction, is increased during HIV-infection and is associated with HIV viral load. Long-lasting HAART seems to decrease cystatin C concentration, thus potentially improves renal function.
Related Concept Videos
Retrovirus Life Cycles
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Serum Studies: Renal Function Tests